The Latest in Gynecologic Cancer

Oncology Practice

Combined PARP, checkpoint inhibitor regimens show ovarian cancer activity

March 29, 2018

Gynecologic Cancer

Oncology Practice

Oncologist-led BRCA mutation testing and counseling may reduce wait times for women with ovarian cancer

March 28, 2018

Oncology Practice

VIDEO: Pelvic radiation surpasses brachytherapy/chemo for early endometrial cancer

March 27, 2018

Gynecologic Cancer

Oncology Practice

VIDEO: Everolimus/letrozole promising for recurrent endometrial cancer

March 25, 2018

Gynecologic Cancer

Oncology Practice

Chlamydia infections associated with more than a doubling of ovarian cancer risk

March 16, 2018

Gynecologic Cancer

Oncology Practice

FDA authorizes first direct-to-consumer BRCA1/2 test

March 6, 2018

Oncology Practice

Avelumab safety compares with other checkpoint inhibitors

March 5, 2018

Oncology Practice

USPSTF: Routine screens for ovarian cancer not recommended

February 13, 2018

Oncology Practice

Letrozole promising as maintenance treatment for high-grade serous ovarian cancer

January 29, 2018

Gynecologic Cancer

Oncology Practice

Pembrolizumab plus SBRT shows promise for advanced solid tumors

January 27, 2018

Oncology Practice

Experimental PD-1/PARP inhibitor combo shows promise in solid tumors

January 26, 2018

Oncology Practice

New multi-analyte blood test shows promise in screening for several common solid tumors

January 19, 2018

Oncology Practice

HIPEC shows survival benefit for advanced ovarian cancer

January 17, 2018

Gynecologic Cancer

Oncology Practice

Age at RRSO affects peritoneal cancer risk in BRCA mutation carriers

January 12, 2018

Oncology Practice

FDA: Laparoscopic power morcellators can spread malignant cells when used in women with occult uterine cancers*

December 19, 2017

Gynecologic Cancer